At 4.2% CAGR, Middle East & Africa Ophthalmology Devices Market is Projected to be Worth US$ 3,033.95 Million by 2031, says Business Market Insights.

According to Business Market Insights' research, the Middle East & Africa ophthalmology devices market was valued at US$ 2,186.05 million in 2023 and is expected to reach US$ 3,033.95 million by 2031, registering a CAGR of 4.2% from 2023 to 2031. Growing focus on telemedicine for eye care services and upsurge in incidence of ophthalmic disorders are among the critical factors attributed to the Middle East & Africa ophthalmology devices market expansion.

With technological advancements in image capturing and data transmission, ophthalmology is strongly embracing telehealth integration. The adoption of technology in delivering remote eye care, known as teleophthalmology, has evolved rapidly with the rapid usage of smartphones and 5th generation (G) wireless communications. Teleophthalmology can be used both asynchronously (store-and-forward) and synchronously (real-time) in the diagnosis, screening, monitoring, and treatment of eye diseases such as age-related macular degeneration, diabetic retinopathy, glaucoma, neuro-ophthalmic disorders, and pediatric ocular diseases, including the retinopathy of prematurity. Moreover, the integration of telehealth in ophthalmology presents strong potential to improve access to screening procedures and treatments. Remote patient monitoring, enabled by this approach, enhances the overall quality of eye care services. Telemedicine and teleophthalmology are already in place since many years, but the practices gained significant importance during the COVID-19 pandemic.

On the contrary, high cost of ophthalmic surgeries hampers the growth of Middle East & Africa ophthalmology devices market.

Based on product, the Middle East & Africa ophthalmology devices market is segmented into vision care products, surgical devices, and diagnostics and monitoring devices. The vision care products segment held 59.9% share of the Middle East & Africa ophthalmology devices market in 2023, amassing US$ 1,310.46 million. It is projected to garner US$ 1,877.90 million by 2031 to expand at 4.6% CAGR during 2023-2031.

In terms of application, the Middle East & Africa ophthalmology devices market is segmented into cataract, glaucoma, refractory disorders, vitreoretinal disorders, and other applications. The glaucoma segment held 44.5% share of the Middle East & Africa ophthalmology devices market in 2023, amassing US$ 973.45 million. It is estimated to garner US$ 1,449.26 million by 2031 to expand at 5.1% CAGR during 2023-2031.

By end user, the Middle East & Africa ophthalmology devices market is segmented into hospital and eye clinics, academic and research laboratories, and other end users. The hospital and eye clinics segment held 72.6% share of Middle East & Africa ophthalmology devices market in 2023, amassing US$ 1,587.16 million. It is predicted to garner US$ 2,247.69 million by 2031 to expand at 4.4% CAGR during 2023-2031.

Based on country, the Middle East & Africa ophthalmology devices market is categorized into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Saudi Arabia held 37.2% share of Middle East & Africa ophthalmology devices market in 2023, amassing US$ 813.85 million. It is projected to garner US$ 1,181.64 million by 2031 to expand at 4.8% CAGR during 2023-2031.

Key players operating in the Middle East & Africa ophthalmology devices market are Johnson & Johnson Vision Care Inc, Alcon AG, Carl Zeiss Meditec, Bausch & Lomb Inc, Essilor Intonational SAS, Nidek Co Ltd, Topcon Corp, and Hoya Corp, among others.


Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com